Jazz Pharmaceuticals initiated with a Buy at UBS
$JAZZ (Jazz Pharmaceuticals) UBS analyst Ashwani Verma initiated coverage of Jazz Pharmaceuticals with a Buy rating and $194 price target as part of a broader research note on U.S. Pharmaceuticals. The company's diversification from childhood epilepsy... 显示更多 翻译
$CWK.L (Cranswick PLC) who is investing?
✅ Visit my profile and consider copying me if and only if you believe that the portfolio is solid.
⭐ 𝗜𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 𝗼𝗯𝗷𝗲𝗰𝘁𝗶𝘃𝗲 ⭐ Outperform the S&P500 Index (Capital Growth + Dividends reinvested) NO leverage
𝗜𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 𝘁𝗵𝗲𝗺𝗲𝘀... 显示更多 翻译
